| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 730044 | 1201482002 | REKAMBYS 900 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA | REKAMBYS 900 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA, 1 vial de 3 ml, 1 jeringa, 1 adaptador del vial y 1 aguja | 900 mg inyectable 3 ml | 45 | 1 | 34 | 1 vial de 3 ml, 1 jeringa, 1 adaptador del vial y 1 aguja | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201482002/1201482002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201482002/1201482002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6153 | LABORATORIOS VIIV HEALTHCARE S.L. | 2021-01-14 | 1 | 1 | 1 | 2021-01-15 | 2021-01-14 | 1 | 2022-11-02 | View Edit Delete | ||||||||||||
| 729825 | 1201483001 | MENQUADFI SOLUCION INYECTABLE | MENQUADFI SOLUCION INYECTABLE, 1 vial de 0,5 ml | N/A (vacuna) | 45 | 1 | 34 | 1 vial de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201483001/1201483001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201483001/1201483001_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41749 | SANOFI AVENTIS S.A. | 2020-12-01 | 1 | 1 | 1 | 2020-12-02 | 2020-12-01 | 1 | 2021-06-11 | View Edit Delete | ||||||||||||
| 763017 | 1201483004 | MENQUADFI SOLUCIÓN INYECTABLE | MENQUADFI SOLUCIÓN INYECTABLE, 10 viales de 0,5 ml | N/A (vacuna) | 45 | 10 | 34 | 10 viales de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201483004/1201483004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201483004/1201483004_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41749 | SANOFI AVENTIS S.A. | 2023-07-17 | 1 | 1 | 1 | 2023-07-18 | 2023-07-17 | 1 | 2024-04-09 | View Edit Delete | ||||||||||||
| 731072 | 1201490005 | LENALIDOMIDA MYLAN 5 mg CAPSULAS DURAS EFG | LENALIDOMIDA MYLAN 5 mg CAPSULAS DURAS EFG, 21 cápsulas | 5 mg | 5 | 21 | 43 | 21 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201490005/1201490005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201490005/1201490005_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32265 | VIATRIS PHARMACEUTICALS S.L.U. | 2021-06-25 | 1 | 1 | 1 | 2021-06-26 | 2021-06-25 | 1 | 2022-01-13 | View Edit Delete | ||||||||||||
| 731073 | 1201490010 | LENALIDOMIDA MYLAN 10 mg CAPSULAS DURAS EFG | LENALIDOMIDA MYLAN 10 mg CAPSULAS DURAS EFG, 21 cápsulas | 10 mg | 5 | 21 | 43 | 21 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201490010/1201490010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201490010/1201490010_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32265 | VIATRIS PHARMACEUTICALS S.L.U. | 2021-06-25 | 1 | 1 | 1 | 2021-06-26 | 2021-06-25 | 1 | 2022-01-13 | View Edit Delete | ||||||||||||
| 731077 | 1201490012 | LENALIDOMIDA MYLAN 15 mg CAPSULAS DURAS EFG | LENALIDOMIDA MYLAN 15 mg CAPSULAS DURAS EFG, 21 cápsulas | 15 mg | 5 | 21 | 43 | 21 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201490012/1201490012_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201490012/1201490012_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32265 | VIATRIS PHARMACEUTICALS S.L.U. | 2021-06-25 | 1 | 1 | 1 | 2021-06-26 | 2021-06-25 | 1 | 2022-01-13 | View Edit Delete | ||||||||||||
| 731074 | 1201490015 | LENALIDOMIDA MYLAN 20 mg CAPSULAS DURAS EFG | LENALIDOMIDA MYLAN 20 mg CAPSULAS DURAS EFG, 21 cápsulas | 20 mg | 5 | 21 | 43 | 21 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201490015/1201490015_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201490015/1201490015_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32265 | VIATRIS PHARMACEUTICALS S.L.U. | 2021-06-25 | 1 | 1 | 1 | 2021-06-26 | 2021-06-25 | 1 | 2022-01-13 | View Edit Delete | ||||||||||||
| 731076 | 1201490018 | LENALIDOMIDA MYLAN 25 mg CAPSULAS DURAS EFG | LENALIDOMIDA MYLAN 25 mg CAPSULAS DURAS EFG, 21 cápsulas | 25 mg | 5 | 21 | 43 | 21 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201490018/1201490018_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201490018/1201490018_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32265 | VIATRIS PHARMACEUTICALS S.L.U. | 2021-06-25 | 1 | 1 | 1 | 2021-06-26 | 2021-06-25 | 1 | 2022-01-13 | View Edit Delete | ||||||||||||
| 731017 | 1201491001 | FINTEPLA 2,2 mg/ml SOLUCION ORAL | FINTEPLA 2,2 mg/ml SOLUCION ORAL, 1 frasco de 120 ml | 2 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201491001/1201491001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201491001/1201491001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 8910 | UCB PHARMA S.A. | 2021-06-02 | 1 | 1 | 1 | 2021-06-03 | 2021-06-02 | 1 | 2023-06-01 | View Edit Delete | ||||||||||||
| 731018 | 1201491001 | FINTEPLA 2,2 mg/ml SOLUCION ORAL | FINTEPLA 2,2 mg/ml SOLUCION ORAL, 1 frasco de 360 ml | 2 mg/ml | 6 | 360 | 26 | 1 frasco de 360 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201491001/1201491001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201491001/1201491001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 8910 | UCB PHARMA S.A. | 2021-06-02 | 1 | 1 | 1 | 2021-06-03 | 2021-06-02 | 1 | 2023-06-01 | View Edit Delete | ||||||||||||
| 729969 | 1201492001 | TECARTUS 0,4 - 2 x 10e8 CELULAS DISPERSION PARA PERFUSION | TECARTUS 0,4 - 2 x 10e8 CELULAS DISPERSION PARA PERFUSION, 1 bolsa de 68 ml | 0,4 - 2 x 10e8 células | 3 | 1 | 65 | 1 bolsa de 68 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201492001/1201492001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201492001/1201492001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 35342 | GILEAD SCIENCES S.L. | 2020-12-28 | 1 | 1 | 1 | 2020-12-29 | 2020-12-28 | 1 | 2024-01-15 | View Edit Delete | ||||||||||||
| 607452 | 1201493001 | LIBMELDY 2-10 X 10^6 CELULAS/ML DISPERSION PARA PERFUSION | LIBMELDY 2-10 X 10^6 CELULAS/ML DISPERSION PARA PERFUSION, una o más bolsas | 2-10 x 10e6 células/ml | 3 | 1 | 70 | una o más bolsas | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201493001/1201493001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201493001/1201493001_p.pdf | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 71597 | ORCHARD THERAPEUTICS (NETHERLANDS) B.V. | 2021-10-19 | 1 | 1 | 1 | 2021-10-20 | 2021-10-19 | 1 | 2025-10-23 | View Edit Delete | ||||||||||||
| 738647 | 1201494001 | LEQVIO 284 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA | LEQVIO 284 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada con protector de aguja | 284 mg inyectable 1,5 ml | 33 | 1 | 61 | 1 jeringa precargada con protector de aguja | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201494001/1201494001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201494001/1201494001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2021-02-03 | 1 | 1 | 1 | 2021-02-04 | 2022-04-29 | 1 | 2023-10-11 | View Edit Delete | ||||||||||||
| 766194 | 1201494001IP | LEQVIO 284 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | LEQVIO 284 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada con protector de aguja | 284 mg inyectable 1,5 ml | 33 | 1 | 61 | 1 jeringa precargada con protector de aguja | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201494001IP/1201494001IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201494001IP/1201494001IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | ABACUS MEDICINE A/S | 2024-11-12 | 1 | 1 | 1 | 2024-11-13 | 2024-11-12 | 1 | 2025-01-10 | View Edit Delete | ||||||||||||
| 729970 | 1201496001 | OXLUMO 94,5 mg/0,5 ml SOLUCION INYECTABLE | OXLUMO 94,5 mg/0,5 ml SOLUCION INYECTABLE, 1 vial de 0,5 ml | 189 mg/ml inyectable 0,5 ml | 45 | 1 | 34 | 1 vial de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201496001/1201496001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201496001/1201496001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 35404 | ALNYLAM PHARMACEUTICALS SPAIN S.L. | 2020-12-30 | 1 | 1 | 1 | 2020-12-31 | 2020-12-30 | 1 | 2022-06-13 | View Edit Delete | ||||||||||||
| 730219 | 1201497001 | PHESGO 1200 MG/600 MG SOLUCION INYECTABLE | PHESGO 1200 MG/600 MG SOLUCION INYECTABLE, 1 vial de 15 ml | 1.200 mg/600 mg inyectable 15 ml | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201497001/1201497001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201497001/1201497001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29096 | ROCHE FARMA S.A. | 2021-02-09 | 1 | 1 | 1 | 2021-02-10 | 2021-02-09 | 1 | 2022-07-27 | View Edit Delete | ||||||||||||
| 768324 | 1201497001IP1 | PHESGO 1200 MG/600 MG SOLUCION INYECTABLE | PHESGO 1200 MG/600 MG SOLUCION INYECTABLE, 1 vial de 15 ml | 1200 mg/600 mg inyectable 15 ml | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201497001IP1/1201497001IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201497001IP1/1201497001IP1_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29096 | ORIFARM A/S | 2025-08-28 | 1 | 1 | 1 | 2025-08-29 | 2025-08-28 | 1 | 2025-10-31 | View Edit Delete | ||||||||||||
| 730249 | 1201497002 | PHESGO 600 MG/600 MG SOLUCION INYECTABLE | PHESGO 600 MG/600 MG SOLUCION INYECTABLE, 1 vial de 10 ml | 600 mg/600 mg inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201497002/1201497002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201497002/1201497002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29096 | ROCHE FARMA S.A. | 2021-02-09 | 1 | 1 | 1 | 2021-02-10 | 2021-02-09 | 1 | 2022-07-27 | View Edit Delete | ||||||||||||
| 768383 | 1201497002IP1 | PHESGO 600 MG/600 MG SOLUCION INYECTABLE | PHESGO 600 MG/600 MG SOLUCION INYECTABLE, 1 vial de 10 ml | 600 mg/600 mg | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201497002IP1/1201497002IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201497002IP1/1201497002IP1_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29096 | ORIFARM A/S | 2025-08-29 | 1 | 1 | 1 | 2025-08-30 | 2025-08-29 | 1 | 2026-03-13 | View Edit Delete | ||||||||||||
| 730100 | 1201498002 | TRIXEO AEROSPHERE 5 microgramos/7,2 microgramos/160 microgramos SUSPENSION PARA INHALACION EN ENVASE A PRESION | TRIXEO AEROSPHERE 5 microgramos/7,2 microgramos/160 microgramos SUSPENSION PARA INHALACION EN ENVASE A PRESION, 1 inhalador (120 inhalaciones) | 5 microgramos/7,2 microgramos/160 microgramos/dosis | 34 | 120 | 30 | 1 inhalador (120 inhalaciones) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201498002/1201498002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201498002/1201498002_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34774 | ASTRAZENECA FARMACEUTICA SPAIN S.A. | 2021-01-14 | 1 | 1 | 1 | 2021-01-15 | 2021-01-14 | 0 | 2022-01-05 | View Edit Delete |
Page 110 of 1036, showing 20 records out of 20704 total, starting on record 2181, ending on 2200